
Nesa Medtech's Fibroid Mapping Reviewer Application (FMRA) has received FDA clearance, revolutionizing uterine fibroid treatment. The advanced technology generates a 3D model of the uterus using ultrasound images, providing crucial insights for planning minimally invasive treatments. This breakthrough is expected to pave the way for subsequent devices offering minimally invasive options for symptomatic uterine fibroid patients, improving outcomes and patient satisfaction.
Like
Save
Share